Hypertension

Doctors may no longer need trial-and-error when prescribing blood pressure drugs. A huge new study has mapped exactly how much each medication, alone or in combos, lowers blood pressure, and offers doctors an online tool to guide treatment.

A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The drug, called baxdrostat, is being hailed as the most promising advance in hypertension management in decades.

A study examined how managing multiple heart disease risk factors reduced the likelihood of premature death faced by people with high blood pressure. Its findings highlight the need for a broad approach to preventing or treating hypertension.